Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 8Glioma 3Breast Neoplasms 3Brain Neoplasms 3Thyroid Neoplasms 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Neoplasms 1Thyroid Nodule 1Thrombocythemia, Essential 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Primary Myelofibrosis 1Precancerous Conditions 1Polycythemia Vera 1

Interventions

Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hemangiopericytoma × Watchful Waiting × Clear all
NCT05259605 2025-12-17

Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification

European Organisation for Research and Treatment of Cancer - EORTC

Recruiting
1,650 enrolled
CNS

Ependymoma, Glioma, Hemangiopericytoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Choroid Plexus Neoplasms, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡